Forbes September 11, 2019
By Arlene Weintraub, Next Avenue Contributor
All 10 Democratic candidates for president who’ve qualified for the debate on Thursday, September 12 have voiced support for various pieces of legislation to lower drug prices. Some of their ideas even align with proposals from President Donald Trump, including letting Medicare negotiate drug prices with pharmaceutical companies. And all would take some freedom away from drug makers for setting, and changing, prices. But are these ideas feasible?
Some drug industry analysts are skeptical, because many of the measures would require Congressional action. “Any president has a very limited ability to act unilaterally when it comes to domestic policy,” says Evan Zoldan, professor of law at the University of Toledo. “It’s not just about...
Today's Sponsors
Today's Sponsor